|
|
DeciZen
|
||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
Q
V+
PT
|
10,664 Small Cap |
4,630.20 (0.00%) |
41.35 | 23.6 | 0.00 | 0.00 |
|
|
| 2 |
Q
V
PT
|
20,590 Small Cap |
8,235.90 (0.00%) |
109.8 | 23.59 | 15.59 | 20.47 |
|
|
| 3 |
Q
V+
PT
|
10,725 Small Cap |
6,461.25 (0.00%) |
32.81 | 20.45 | 4.31 | 11.97 |
|
|
| 4 |
Q
V+
PT
|
1,57,804 Large Cap |
4,662.60 (0.00%) |
72.94 | 18.81 | 11.80 | 13.74 |
|
|
| 5 |
Q
V+
PT
|
30,212 Small Cap |
3,690.15 (0.00%) |
82.51 | 18.11 | 32.80 | 16.82 |
|
|
| 6 |
Q
V
PT
|
40,928 Mid Cap |
2,415.95 (0.00%) |
39.51 | 17.93 | 5.49 | 17.52 |
|
|
| 7 |
Q
V+
PT
|
22,733 Small Cap |
1,374.55 (0.00%) |
120.81 | 16.8 | 32.49 | 25.95 |
|
|
| 8 |
Q
V+
PT
|
12,287 Small Cap |
2,009 (0.00%) |
66.47 | 16.47 | 19.49 | 18.67 |
|
|
| 9 |
Q
V+
PT
|
82,399 Mid Cap |
1,525.20 (0.00%) |
92.71 | 15.62 | 7.19 | -2.25 |
|
|
| 10 |
Q
V+
PT
|
8,863 Small Cap |
556.85 (0.00%) |
54.24 | 15.31 | 10.88 | 8.62 |
|
|
| 11 |
Q
V+
PT
|
14,395 Small Cap |
1,399 (0.00%) |
83.22 | 15.04 | 15.00 | 18.43 |
|
|
| 12 |
Q
V+
PT
|
4,313 Small Cap |
395.80 (0.00%) |
92.39 | 14.99 | 12.12 | 15.55 |
|
|
| 13 |
Q
V+
PT
|
12,442 Small Cap |
288.05 (0.00%) |
339.79 | 14.47 | 0.00 | 0.00 |
|
|
| 14 |
Q
V
PT
|
43,454 Mid Cap |
771.30 (0.00%) |
64.8 | 13.64 | 23.81 | 40.64 |
|
|
| 15 |
Q
V+
PT
|
24,354 Small Cap |
18,982.30 (0.00%) |
67.07 | 13.06 | 14.13 | 64.99 |
|
|
| 16 |
Q
V+
PT
|
1,25,057 Large Cap |
8,697.55 (0.00%) |
83.78 | 12.55 | -3.49 | 29.94 |
|
|
| 17 |
Q
V+
PT
|
3,353 Small Cap |
547.35 (0.00%) |
N/A | 11.75 | -8.75 | 0.00 |
|
|
| 18 |
Q
V
PT
|
27,697 Small Cap |
1,652.20 (0.00%) |
54.5 | 11.51 | 12.18 | 13.26 |
|
|
| 19 |
Q
V
PT
|
54,657 Mid Cap |
25,721.65 (0.00%) |
35.22 | 11.45 | 9.38 | 18.78 |
|
|
| 20 |
Q
V
PT
|
1,77,179 Large Cap |
6,674.20 (0.00%) |
69 | 10.57 | 11.65 | 10.50 |
|
|
| 21 |
Q
V+
PT
|
26,284 Small Cap |
1,238.15 (0.00%) |
76.97 | 10.48 | 17.75 | 11.20 |
|
|
| 22 |
Q
V
PT
|
8,006 Small Cap |
3,476.10 (0.00%) |
25.84 | 10.26 | -8.74 | -7.50 |
|
|
| 23 |
Q
V+
PT
|
1,09,728 Mid Cap |
1,127.45 (0.00%) |
76.07 | 10.21 | 46.01 | 60.18 |
|
|
| 24 |
Q
V
PT
|
35,178 Small Cap |
1,854.60 (0.00%) |
47.99 | 9.48 | 13.02 | 9.98 |
|
|
| 25 |
Q
V+
PT
|
41,776 Mid Cap |
3,343.80 (0.00%) |
39.56 | 9.23 | 13.54 | 10.92 |
|
|
| 26 |
Q
V+
PT
|
37,225 Small Cap |
2,318.45 (0.00%) |
55.22 | 9.22 | 15.51 | 9.89 |
|
|
| 27 |
Q
V
PT
|
36,177 Small Cap |
1,345.50 (0.00%) |
72.91 | 9 | 16.83 | 34.86 |
|
|
| 28 |
Q
V+
PT
|
40,963 Mid Cap |
790.60 (0.00%) |
105.54 | 8.95 | -13.71 | 0.61 |
|
|
| 29 |
Q
V
PT
|
40,571 Mid Cap |
1,985.25 (0.00%) |
50.36 | 8.94 | 11.88 | 45.85 |
|
|
| 30 |
Q
V
PT
|
35,098 Small Cap |
835.65 (0.00%) |
134.63 | 8.93 | 11.87 | 17.04 |
|
|
| Rank | Company | Market Capitalization 2026 (INR crores) |
|---|---|---|
| 1 | Sanofi Consumer Healthcare India Ltd. | 10,664 Crore |
| 2 | Astrazeneca Pharma India Ltd. | 20,590 Crore |
| 3 | Procter & Gamble Health Ltd. | 10,725 Crore |
| 4 | Torrent Pharmaceuticals Ltd. | 1,57,804 Crore |
| 5 | Acutaas Chemicals Ltd. | 30,212 Crore |
| 6 | Glaxosmithkline Pharmaceuticals Ltd. | 40,928 Crore |
| 7 | Rubicon Research Ltd. | 22,733 Crore |
| 8 | CORONA Remedies Ltd. | 12,287 Crore |
| 9 | Laurus Labs Ltd. | 82,399 Crore |
| 10 | Thyrocare Technologies Ltd. | 8,863 Crore |
You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.
Based on ROE, the best stocks in the Nifty Pharma companies index are:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | ROE |
|---|---|---|---|---|---|---|---|
| Abbott India Ltd. (M) | Very Good | 25,722 | 54,657 | 35.22 | 11.45 | 24.04 | 35.71 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,663 | 1,57,804 | 72.94 | 18.81 | 38.40 | 29.04 |
| Ajanta Pharma Ltd. (M) | Very Good | 3,344 | 41,776 | 39.56 | 9.23 | 26.73 | 25.35 |
| Lupin Ltd. (M) | Somewhat Good | 2,399 | 1,09,676 | 20.57 | 4.89 | 11.90 | 20.83 |
| Zydus Lifesciences Ltd. (M) | Very Good | 1,100 | 1,09,691 | 21.76 | 4.22 | 13.36 | 20.74 |
Based on the past year's gain, the best performing stocks are:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | Yearly gain (%) |
|---|---|---|---|---|
| Laurus Labs Ltd. (M) | Very Good | 1,525 | 82,399 | 101 |
| JB Chemicals & Pharmaceuticals Ltd. (S) | Very Good | 2,318 | 37,225 | 41.28 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,663 | 1,57,804 | 39.25 |
| Aurobindo Pharma Ltd. (M) | Very Good | 1,560 | 89,762 | 34.75 |
| Ajanta Pharma Ltd. (M) | Very Good | 3,344 | 41,776 | 31.18 |
| View More |
Stocks with the highest revenue growth in the past 5 years is:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | 5Y Sales Growth (%) |
|---|---|---|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals Ltd. (S) | Very Good | 2,318 | 37,225 | 55.22 | 9.22 | 33.44 | 15.51 |
| Mankind Pharma Ltd. (M) | Very Good | 2,487 | 1,02,729 | 50.42 | 6.27 | 31.67 | 14.65 |
| Ajanta Pharma Ltd. (M) | Very Good | 3,344 | 41,776 | 39.56 | 9.23 | 26.73 | 13.54 |
| Dr. Reddys Laboratories Ltd. (M) | Very Good | 1,346 | 1,12,368 | 26.78 | 2.98 | 14.95 | 12.09 |
| Torrent Pharmaceuticals Ltd. (L) | Very Good | 4,663 | 1,57,804 | 72.94 | 18.81 | 38.40 | 11.80 |
Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.
Stocks with the highest profit growth in the past 5 years is:
| Company Name | Is it a Right Stock ? | CMP | Market Cap(Cr.) | P/E | P/BV | EV/EBITDA | 5Y Profit Growth (%) |
|---|---|---|---|---|---|---|---|
| Zydus Lifesciences Ltd. (M) | Very Good | 1,100 | 1,09,691 | 21.76 | 4.22 | 13.36 | 30.57 |
| Sun Pharmaceutical Industries Ltd. (L) | Very Good | 1,872 | 4,49,048 | 39.12 | 5.37 | 22.41 | 23.50 |
| Abbott India Ltd. (M) | Very Good | 25,722 | 54,657 | 35.22 | 11.45 | 24.04 | 18.78 |
| Dr. Reddys Laboratories Ltd. (M) | Very Good | 1,346 | 1,12,368 | 26.78 | 2.98 | 14.95 | 15.75 |
| Glenmark Pharmaceuticals Ltd. (M) | Very Good | 2,195 | 61,943 | 45.48 | 5.89 | 12.07 | 14.41 |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: